Novartis Archives - Express Pharma

PHARMAP 2025 brings together global pharma leaders to discuss innovation and drug safety

CNS market to surpass $80 bn in 2025, driven by MS and psychiatric drug innovation: GlobalData

Radiopharmaceuticals for prostate cancer to go nuclear with $6.3 bn in sales by 2030

Novartis’ kidney disease drug Fabhalta receives US FDA approval

Pharma industry focuses on strategic investments amid reduced deal activity by 26.1 % compared to May 2023: GlobalData

Transition times in the pharma universe

JB Pharma inks Rs 1,089 crore pact with Novartis for select ophthalmology brands

Novartis acquires DTx Pharma

Novartis warns US plan to curb drug prices could hit key research

Dr Reddy’s reduces price of cardiovascular drug Cidmus